1. Platelet factor-4 concentration in adult veno-arterial ECMO patients.
- Author
-
Mazzeffi, Michael, Clark, Madeline, Grazioli, Alison, Dugan, Colleen, Rector, Raymond, Dalton, Heidi, Madathil, Ronson, Menaker, Jay, Herr, Daniel, and Tanaka, Kenichi
- Subjects
HEART failure treatment ,PARTIAL thromboplastin time ,REFERENCE values ,PULMONARY embolism ,EXTRACORPOREAL membrane oxygenation ,MANN Whitney U Test ,COMPARATIVE studies ,RISK assessment ,CARDIOGENIC shock ,GLYCOPROTEINS ,DESCRIPTIVE statistics ,RESEARCH funding ,HEPARIN ,THROMBOCYTOPENIA ,DATA analysis software ,DISEASE risk factors ,ADULTS - Abstract
Background: Heparin induced thrombocytopenia (HIT) is reported at a variable rate in extracorporeal membrane oxygenation (ECMO) patients. A critical factor impacting platelet factor-4 (PF4)-heparin antibody formation is plasma PF4 concentration. We hypothesized that PF4 concentration would be increased during veno-arterial (VA) ECMO. Methods: Plasma PF4 concentration was measured during the first 5 ECMO days in 20 VA ECMO patients and 10 control plasma samples. PF4-heparin ratios were estimated using an assumed heparin concentration of 0.4 IU/mL. This correlates with an activated partial thromboplastin time of 60 to 80 seconds, which is the anticoagulation target in our center. Results: Twenty VA ECMO patients were enrolled, 10 of which had pulmonary embolism. Median PF4 concentration was 0.03 µg/mL [0.01, 0.13] in control plasma. Median PF4 concentration was 0.21 µg/mL [0.12, 0.34] on ECMO day 1 or 2, 0.16 µg/mL [0.09, 0.25] on ECMO day 3, and 0.12 µg/mL [0.09, 0.22] on ECMO day 5. Estimated median PF4-heparin ratios were 0.04, 0.03, and 0.02 respectively. Two patients (10%) developed HIT that was confirmed by serotonin release assay. PF4 concentration did not differ significantly in these patients compared to non-HIT patients (p = 0.37). No patient had an estimated PF4-heparin ratio between 0.7 and 1.4, which is the reported optimal range for PF4-heparin antibody formation. Conclusion: Our data suggest that PF4 concentration is mildly elevated during VA ECMO compared to control plasma. Estimated PF4-heparin ratios were not optimal for HIT antibody formation. These data support epidemiologic studies where HIT incidence is low during VA ECMO. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF